Browsing publications by Dr Elaine Willmore

Newcastle AuthorsTitleYearFull text
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Patterson
et al.
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Laura Evans
Dr Lindi Chen
Dr Elaine Willmore
Professor Herbie Newell
Professor Deborah Tweddle
et al.
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma2015
Andrew Shouksmith
Laura Evans
Professor Deborah Tweddle
Duncan Miller
Dr Elaine Willmore
et al.
Synthesis and Activity of Putative Small-​Molecule Inhibitors of the F-​Box Protein SKP22015
Emily Mould
Philip Berry
Dr David Jamieson
Dr Chris Hill
Dr Celine Cano
et al.
Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity2014
Pawel Znojek
Dr Elaine Willmore
Professor Nicola Curtin
Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase2014
Dr Alessio Iannetti
Dr Adeline Ledoux
Dr Susan Tudhope
Helene Sellier
Adam Moore
et al.
Regulation of p53 and Rb Links the Alternative NF-kappa B Pathway to EZH2 Expression and Cell Senescence2014
Emily Mould
Philip Berry
Dr David Jamieson
Dr Chris Hill
Niu Tan
et al.
The DNA-PK inhibitor, NU7441, sensitises cancer cells to microtubule-targeting agents and modulates vincristine efflux in multidrug resistant cells2013
Shilu Amin
Dr Meagan Walsh
Dr Caroline Wilson
Dr Elaine Willmore
Professor Derek Mann
et al.
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL2012
Dr Elaine Willmore
Natalie Rodrigues
Dr Jonathan Wallis
Professor Nicola Curtin
High Activity of Poly(ADP-Ribose) Polymerase in Chronic Lymphocytic Leukemia2012
Dr Jill Hunter
Dr Elaine Willmore
Dr Julie Irving
Dr Stephany Veuger
Emeritus Professor Barbara Durkacz
et al.
NF-kappa B mediates radio-sensitization by the PARP-1 inhibitor, AG-0146992012
12345